1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output


Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the ‘Rete Ematologica Pugliese E Basilicata’

Mele, G., Pastore, D., Di Renzo, N., Fragasso, A., Guarini, A., Mazza, P., Musto, P., Pavone, V., Tarantini, G., Curci, P., Falcone, A. P., Mele, A., Miccolis, M. R., Palazzo, G., Palumbo, G., Quinto, A. M., Reddiconto, G., Rizzi, R., Cascavilla, N., Specchia, G. & 1 others, Capalbo, S. F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter


A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach

Lanza, F., Saraceni, F., Pezzi, A., Martino, M., Bosi, A., Cascavilla, N., Musto, P., Zuffa, E., Tani, M., Cellini, C., Laszlo, D., Bonifazi, F. & on behalf of GITMO (Italian Society for Transplantation), Sep 1 2017, In : American Journal of Hematology. 92, 9, p. E557-E559

Research output: Contribution to journalLetter